Excimer 308-nm laser for the treatment of frontal fibrosing alopecia: an observational study in 30 patients - Takeaways - MDSpire

Excimer 308-nm laser for the treatment of frontal fibrosing alopecia: an observational study in 30 patients

  • By

  • Blanca Ferrer Guillén

  • Ana Rodríguez-Villa Lario

  • José María Ricart Vaya

  • Alba Gómez Zubiaur

  • June 15, 2026

  • 0 min

Share

  • 1

    Frontal fibrosing alopecia (FFA) is a challenging condition with limited effective treatments and significant impact on patients' quality of life.

  • 2

    The study involved 30 patients, predominantly women, with a mean age of 65.2 years, all of whom had previously received treatments for FFA.

  • 3

    After 6 months of 308-nm excimer laser treatment, 53.3% of patients showed stabilization of hairline recession, while 20% experienced improvement.

  • 4

    Erythema improved in 83.3% of patients, and 70% showed improvement in perifollicular hyperkeratosis, with transient erythema as the only adverse effect.

  • 5

    The 308-nm excimer laser appears to be a promising adjuvant treatment for symptomatic FFA, demonstrating efficacy and a favorable safety profile.

Original Source(s)

Excimer 308-nm laser for the treatment of frontal fibrosing alopecia: an observational study in 30 patients

  • by Blanca Ferrer Guillén, Ana Rodríguez-Villa Lario, José María Ricart Vaya, Alba Gómez Zubiaur

  • June 15, 2026

Related Content

Enhanced Diagnosis of Generalized Pustular Psoriasis With the Legit.Health Device as a Diagnosis Support Tool: Multireader Multicase Study

Tracing the clinicodermoscopic and histopathological evolution of acquired reactive perforating collagenosis: a case report

When Bad Data Enters the Drug Pipeline

Federal prosecutors allege that a Florida physician and research staff fabricated clinical trial records that were submitted into database systems used to evaluate investigational drugs.